It's kind of bonkers that estrogen HRT for transfems is still basically an "off-label" use for the medication.
-
It's kind of bonkers that estrogen HRT for transfems is still basically an "off-label" use for the medication.
I was given an assignment to write a poem based upon a common documentation format, so chose to go with medication instructions and warnings paperwork. Reading the documentation for my estradiol, it's kind of hilarious to see that the uses are still just: menopause and ovarian failure for cis women or to treat prostate cancer in cis men. Trans women and transfeminine people are still not being considered one of the primary patient groups being treated by the medication in 2026.
@JoscelynTransient
listing transition as one of the uses of estradiol, might encourage more cis men to scott adams themselves. which is to say, do it
-
@JoscelynTransient I had to sign a waiver saying I knew I am taking my testosterone for off-label reasons. Lots of warnings about not letting it touch a woman. It's just for men whose dick don't work good.
@bright_helpings @JoscelynTransient expelling the air from a syringe of t and accidentally getting a drop on a woman, immediately causing her to writhe on the floor and spore off several angry little guys like a mogwai
-
@JoscelynTransient@chaosfem.tw I find T-blockers even funnier for this. Like side-effects of cyproterone are erectile dysfunction. Side-effect? No, that's a main-effect for a lot of transfems
@PurpleStephyr @JoscelynTransient
Erectile dysfunction is a permanent part of my medical record for some reason even though it's on purpose.
-
It's kind of bonkers that estrogen HRT for transfems is still basically an "off-label" use for the medication.
I was given an assignment to write a poem based upon a common documentation format, so chose to go with medication instructions and warnings paperwork. Reading the documentation for my estradiol, it's kind of hilarious to see that the uses are still just: menopause and ovarian failure for cis women or to treat prostate cancer in cis men. Trans women and transfeminine people are still not being considered one of the primary patient groups being treated by the medication in 2026.
@JoscelynTransient this is weird but maybe understandable: labeled use usually (in the US) requires an FDA approval process, which requires a certain level of scientific evidence, which requires at least somewhat representative samples in treatment trials. This kind of research for HRT seems like it might be lacking, at least partly because of political shenanigans to restrict it, bit also probably because trans people willing to participate in drug trials might be a really small number... Which is almost certainly influenced by general and medical prejudice.
Not saying the pharmaceutical industry couldn't also be playing "appease the status quo sensibilities" for a few decades.
-
R relay@relay.infosec.exchange shared this topic
